Patent · US Active

Catechol group modified biomacromolecular scaffold material and preparation method thereof

US11384162B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2017
Grant dateJul 12, 2022
Priority date
Expiry dateAug 28, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/02
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The invention discloses a preparation method of a catechol group modified biomacromolecular scaffold material, comprising: grafting a catechol-containing compound by amidation to obtain modified biomacromolecules; then, allowing dopamine to perform oxidized self-polymerization in a weakly alkaline buffer solution to form polydopamine (PDA) particles with a uniform particle size; next, forming a scaffold which has three cross-linking structures, namely modified biomacromolecules, modified biomacromolecules/PDA, and biomacromolecules/PDA, through interaction between catechol groups, interaction between catechol groups and PDA particles, and interaction between macromolecules and PDA particles in the modified macromolecules respectively; and cross-linking the scaffold with calcium ions, adipic dihydrazide or genipin to further adjust the degree of cross-linking and porosity of the scaffold. The prepared scaffold material has excellent biocompatibility and biodegradability, can promote cell adhesion, and has a wide application prospect in the field of tissue repair and regeneration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.